XEN496 (Ezogabine) in Children With KCNQ2 Developmental and Epileptic Encephalopathy
Clinical trial NCT04639310 · TERMINATED
Trial details
- NCT number
- NCT04639310
- Sponsor
- Xenon Pharmaceuticals Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-29
- Primary completion
- 2023-05-16
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.